# IntelGenx Corp. – FDA Inspection, Jan 25, 2019

Source: https://www.keypedia.com/records/fda_inspections/intelgenx-corp/5aa8b5c2-0f37-4dc6-800e-478733429abf
Source feed: FDA_Inspections

> FDA inspection 1077109 of IntelGenx Corp., January 25, 2019. 5 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1077109
- Company Name: IntelGenx Corp.
- Inspection Date: 2019-01-25
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 5

## Related Documents

- [FDA Inspection 1204406 - 2023-03-24](https://www.keypedia.com/records/fda_inspections/intelgenx-corp/32597512-b180-456a-87eb-05164a51ae69)
- [FDA Inspection 1092982 - 2019-06-14](https://www.keypedia.com/records/fda_inspections/intelgenx-corp/74fbd5c9-7838-463d-bca6-c8c0e6ec0025)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/liming-zhang/6c93b721-8725-4d87-8a42-254f3de5e49d)

Company: https://www.keypedia.com/companies/intelgenx-corp/94028878-3a72-4a00-afee-6e3439e993eb

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8